Regional fat deposition and cardiovascular risk in HIV infection: the FRAM study.
about
HIV infection and cardiovascular diseaseThe development of simple anthropometric measures to diagnose antiretroviral therapy-associated lipodystrophy in resource limited settingsAdipokines and vascular health in treated HIV infection: an obesity paradox?Combined use of waist and hip circumference to identify abdominally obese HIV-infected patients at increased health risk.Anthropometric differences between HIV-infected individuals prior to antiretroviral treatment and the general population from 1998-2007: the AIDS Clinical Trials Group Longitudinal Linked Randomized Trials (ALLRT) cohort and NHANES.The association of adiposity with kidney function decline among HIV-infected adults: findings from the Fat Redistribution and Metabolic Changes in HIV Infection (FRAM) studyAdiponectin and interleukin-6, but not adipose tissue, are associated with worse neurocognitive function in HIV-infected menPredictors of Treatment Response to Tesamorelin, a Growth Hormone-Releasing Factor Analog, in HIV-Infected Patients with Excess Abdominal Fat.Body composition and metabolic changes in HIV-infected patientsPeople living with HIV on ART have accurate perception of lipodystrophy signs: a cross-sectional study.Physical fitness in children infected with the human immunodeficiency virus: associations with highly active antiretroviral therapyA pilot study of telmisartan for visceral adiposity in HIV infection: the metabolic abnormalities, telmisartan, and HIV infection (MATH) trial.CD4/CD8 Ratio Predicts Peripheral Fat in HIV-Infected Population.Increased FDG uptake in association with reduced extremity fat in HIV patients.Anatomic Fat Depots and Coronary Plaque Among Human Immunodeficiency Virus-Infected and Uninfected Men in the Multicenter AIDS Cohort StudyPerivascular fat, inflammation, and cardiovascular risk in HIV-infected patients on antiretroviral therapyHeart fat in HIV: marker or mediator of risk?Practical Review of Recognition and Management of Obesity and Lipohypertrophy in Human Immunodeficiency Virus Infection.HIV and ageing: improving quantity and quality of life.Changes in abdominal fat following antiretroviral therapy initiation in HIV-infected individuals correlate with waist circumference and self-reported changes.Metabolic and Cardiovascular Complications in HIV/HCV-Co-infected Patients.Aging metabolism: intervention strategies.Improvement of BMD after Switching from Lopinavir/R Plus Two Nucleos(T)ide Reverse Transcriptase Inhibitors to Lopinavir/R Plus Lamivudine: OLE-LIP Substudy.Highly active antiretroviral therapy dysregulates proliferation and differentiation of human pre-adipocytes.Body changes: antiretroviral therapy and lipodystrophy syndrome in people living with HIV/AIDS.Abdominal Fat Depots and Subclinical Carotid Artery Atherosclerosis in Women with and without HIV Infection.Telmisartan Does Not Improve Lymph Node or Adipose Tissue Fibrosis More Than Continued ART Alone.
P2860
Q27008915-D76EDF48-2CD8-4B6A-B402-1A25E0D73E2CQ34067682-B655D33D-A44A-401B-B2AC-AD8CDBD366ECQ34075808-B09F19FD-259C-49BC-AD03-EBA317E63A50Q34734960-70D2539C-BBDE-40EA-B129-071F2CD235F5Q34766373-E8B8882C-3550-4327-8496-F7A33A21F9C6Q35060772-8EDDF8E2-1E16-4DC9-B245-48C8C0ABB246Q35587294-6005F88F-5A9A-493C-AEDF-02194138960FQ35803315-0EC3F689-FFAF-47BB-9C2A-1FADB11FF60AQ35949965-D5BE7C59-D4A6-4522-87D2-7B848CC0E027Q36249550-0E5FB782-9C45-4A1F-B11B-6153BAC34885Q36509694-9BEA59D9-3602-490D-B5FB-01E071B29958Q36684708-733B2683-E9D9-4012-A06F-C5D1BDFA1206Q36813651-8788B401-405A-4A24-A379-D006A5DE9B35Q36897050-8FC58764-3A66-4A0A-BB94-322787C1BBE2Q37091664-C470D502-2065-4F03-B173-E1742FEDD9DFQ37248840-B74BA6AD-1E30-49DB-8CDF-E5E1C0A91325Q38630822-BE1C4B1A-F9FF-4CCD-8EE8-4EF856B5F391Q38741518-3C7BB8BC-17DC-48B4-AD20-4519F2BC0EE0Q38883328-75108F19-18BE-4508-B9F6-B821C79BB2D0Q38936060-6CAFA10F-DABE-4BC0-A3FC-DA650C2320E7Q38946641-AFE6F800-7504-4084-8759-87E5234E6649Q40296763-A4A2B421-E8BB-437E-9585-B93F390FB653Q40695106-5B71042F-A699-49A9-B245-05BF6433DD03Q41450474-BFE99A10-AFB8-475D-8E34-99EFA36CEB7AQ43586525-D61D4E8E-AC8B-4820-8353-5FCCB236D21DQ46361539-697DB0F6-915E-43E8-8175-44A69F8C6EA5Q51755304-07D9AEFF-405D-4041-9F13-6AF526932E64
P2860
Regional fat deposition and cardiovascular risk in HIV infection: the FRAM study.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Regional fat deposition and cardiovascular risk in HIV infection: the FRAM study.
@ast
Regional fat deposition and cardiovascular risk in HIV infection: the FRAM study.
@en
type
label
Regional fat deposition and cardiovascular risk in HIV infection: the FRAM study.
@ast
Regional fat deposition and cardiovascular risk in HIV infection: the FRAM study.
@en
prefLabel
Regional fat deposition and cardiovascular risk in HIV infection: the FRAM study.
@ast
Regional fat deposition and cardiovascular risk in HIV infection: the FRAM study.
@en
P2093
P2860
P1433
P1476
Regional fat deposition and cardiovascular risk in HIV infection: the FRAM study.
@en
P2093
Carl Grunfeld
David Wohl
Jordan E Lake
Judith S Currier
Phyllis C Tien
Rebecca Scherzer
Stephen Sidney
P2860
P304
P356
10.1080/09540121.2010.543885
P577
2011-06-24T00:00:00Z